EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Multidimensional Evaluation of Lisdexamfetamine: Pharmacology, Therapeutic Use, Toxicity and Forensic Implications

Mariana Silva-Carvalho iD, Daniel José Barbosa, Diana Dias da Silva iD, Ricardo Jorge Dinis-Oliveira iD

Basic & Clinical Pharmacology & Toxicology · 2025

DOI: 10.1111/bcpt.70111 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, 2025. Verfasst von Mariana Silva-Carvalho und 3 weiteren Autor:innen. Beteiligte Einrichtung: Associate Laboratory i4HB-Institute for Health and Bioeconomy, University Institute of Health Sciences-IUCS-CESPU, Gandra, Portugal. Hauptthemen laut MEDLINE: Lisdexamfetamine Dimesylate, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity. Die Arbeit nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lisdexamfetamine (LDX), a prodrug of d ‐amphetamine, is widely used in the pharmacological treatment of neuropsychiatric disorders such as attention‐deficit/hyperactivity disorder (ADHD) and binge eating disorder (BED). Chemically, it consists of the amino acid lysine linked to d ‐amphetamine. Its enzymatic conversion to d ‐amphetamine sets the stage for a prolonged and controlled release, influencing its clinical profile and differentiating it from other stimulant medications. As a central nervous system stimulant, LDX primarily acts by increasing the release of neurotransmitters, particularly dopamine and noradrenaline, in the brain. Clinically, this enhanced availability of neurotransmitters is believed to contribute to improvements in attention, focus and impulse control in individuals with ADHD. The side effects of LDX include insomnia, decreased appetite, weight loss and xerostomia. This work reviews the pharmacological mechanisms, clinical applications and forensic considerations associated with its use. It is expected that clinicians, researchers and policymakers have a comprehensive understanding of the pharmacological and toxicological aspects of LDX.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lisdexamfetamine DimesylateCentral Nervous System StimulantsAttention Deficit Disorder with HyperactivityHumansAnimalsBinge-Eating DisorderProdrugs

Stichwörter der Autor:innen

attention‐deficit/hyperactivity disorderd‐amphetaminelisdexamfetaminepharmacodynamicspharmacokinetics

Substanzen

Lisdexamfetamine DimesylateCentral Nervous System StimulantsProdrugs

Autor:innen und Institutionen

  • Associate Laboratory i4HB-Institute for Health and Bioeconomy, University Institute of Health Sciences-IUCS-CESPU, Gandra, Portugal.
  • UCIBIO-Research Unit on Applied Molecular Biosciences, Translational Toxicology Research Laboratory (1H-TOXRUN), University Institute of Health Sciences (IUCS-CESPU), Gandra, Portugal.
  • REQUIMTE/LAQV, ESS, Polytechnic of Porto, Porto, Portugal.
  • Associate Laboratory i4HB-Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, Porto, Portugal.
  • UCIBIO-Applied Molecular Biosciences Unit, Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Porto, Portugal.
  • Department of Public Health and Forensic Sciences and Medical Education, Faculty of Medicine, University of Porto, Porto, Portugal.

ORCID-Profile: Mariana Silva-Carvalho, Diana Dias da Silva, Ricardo Jorge Dinis-Oliveira

Zitieren

APA

Silva-Carvalho, M., Barbosa, D. J., Dias da Silva, D., & Dinis-Oliveira, R. J. (2025). Multidimensional Evaluation of Lisdexamfetamine: Pharmacology, Therapeutic Use, Toxicity and Forensic Implications. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.70111

Vancouver

Silva-Carvalho M, Barbosa DJ, Dias da Silva D, Dinis-Oliveira RJ. Multidimensional Evaluation of Lisdexamfetamine: Pharmacology, Therapeutic Use, Toxicity and Forensic Implications. Basic & Clinical Pharmacology & Toxicology. 2025. doi:10.1111/bcpt.70111

BibTeX
@article{SilvaCarvalho2025,
  author = {Silva-Carvalho, Mariana and Barbosa, Daniel José and Dias da Silva, Diana and Dinis-Oliveira, Ricardo Jorge},
  title = {Multidimensional Evaluation of Lisdexamfetamine: Pharmacology, Therapeutic Use, Toxicity and Forensic Implications},
  journal = {Basic & Clinical Pharmacology & Toxicology},
  year = {2025},
  doi = {10.1111/bcpt.70111}
}
Kostenlos starten →